A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer’s respiratory syncytial virus (RSV) vaccine, bringing it closer to becoming one of the first approved RSV shots for older adults in the United States.
U.S. expert panel backs Pfizer’s RSV vaccine for older adults
Date:
